Andrew R Robbins
CIK 1590157 · President and CEO · last filed 2026-05-21
Andrew R Robbins is a President and CEO who has filed 30 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for COGT, was dated May 21, 2026. Current disclosed insider exposure totals $21.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$21.76M
2
30
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | President and CEO | 657,503 | $33.10 | $21.76M | $0 | 9 | 2026-05-21 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Director | 0 | $23.01 | $0 | $0 | 7 | 2024-03-11 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | COGT | Gift (G) | — | $0 | EDGAR |
| 2025-12-19 | COGT | Mixed | +657,503 | -$14.50M | EDGAR |
| 2025-01-27 | COGT | Grant (A) | — | $0 | EDGAR |
| 2024-03-11 | Harpoon Therapeutics, Inc. (HARP) Delisted | Disp (D) | −5,000 | $0 | EDGAR |
| 2024-01-25 | COGT | Grant (A) | — | $0 | EDGAR |
| 2023-11-28 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2023-06-23 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-15 | COGT | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | COGT | Grant (A) | — | $0 | EDGAR |